Axin, a negative regulator of Wnt signaling, is a key scaffold protein for the b-catenin destruction complex. It has been previously shown that multiple post-translational modification enzymes regulate the level of Axin. Here, we provide evidence that protein arginine methyltransferase 1 (PRMT1) directly interacts with and methylates the 378th arginine residue of Axin both in vitro and in vivo. We found that the transient expression of PRMT1 led to an increased level of Axin and that knockdown of endogenous PRMT1 by short hairpin RNA reduced the level of Axin. These results suggest that methylation by PRMT1 enhanced the stability of Axin. Methylation of Axin by PRMT1 also seemingly enhanced the interaction between Axin and glycogen synthase kinase 3b, leading to decreased ubiquitination of Axin. Consistent with the role of PRMT1 in the regulation of Axin, knockdown of PRMT1 enhanced the level of cytoplasmic b-catenin as well as b-catenin-dependent transcription activity. In summary, we show that the methylation of Axin occurred in vivo and controlled the stability of Axin. Therefore, methylation of Axin by PRMT1 may serve as a finely tuned regulation mechanism for Wnt/b-catenin signaling.
Introduction
Wnt signaling has important roles in embryonic development, regulation of cell proliferation and cell fate decision-making (Cadigan and Nusse, 1997; Moon et al., 1997) . In addition, aberrant Wnt signaling in adult tissues leads to a variety of human diseases including cancer (Bienz and Clevers, 2000; Polakis, 2000) . In the absence of Wnt activation, cytoplasmic b-catenin is assembled in a multimeric protein complex comprising Axin, adenomatous polyposis coli, casein kinase 1 (CK1) and glycogen synthase kinase 3b (GSK3b; Kimelman and Xu, 2006) , after which it is sequentially phosphorylated at its Ser and Thr residues by CK1 and GSK3b, respectively (Liu et al., 2002) , and degraded via the b-TrCP-mediated ubiquitin-proteasome pathway (Latres et al., 1999; Winston et al., 1999) . Upon Wnt stimulation, the Wnt ligand binds to the frizzled receptor and LRP5/6 co-receptors, forming a multimeric membrane receptor complex (Cong et al., 2004; Zeng et al., 2008) in which the cytoplasmic domain of LRP5/6 is highly phophorylated by GSK3b and CK1 at multiple PPPSPxS sites. These phosphorylated PPPSPxS motifs serve as docking sites for Axin binding (Davidson et al., 2005; Zeng et al., 2005) . Thus, Wnt activation leads to the disintegration of the b-catenin destruction complex via translocation of Axin to membrane, resulting in stabilization of cytoplasmic b-catenin (MacDonald et al., 2009) . Stabilized b-catenin is then translocated into nuclei where it binds to Tcf/Lef1 and activates the expression of genes involved in the regulation of cell proliferation (c-myc or cyclin D1 and so on) or differentiation (brachury or siamois and so on) (http://www.stanford.edu/Brnusse/wntwindow.html).
Axin is a key scaffold protein for the b-catenin destruction complex, and mutation of Axin leads to various cancers (Salahshor and Woodgett, 2005) . The presence of mutated Axin in human colorectal cancer and hepatocellular carcinomas suggest that Axin is a tumor suppressor gene as well as a potential therapeutic target molecule for various types of cancer (Satoh et al., 2000; Shimizu et al., 2002) . It has been reported that the concentration of Axin is extremely low compared with any other component of the Wnt signaling pathway, suggesting that Axin is a rate-limiting factor for the b-catenin destruction complex (Lee et al., 2003) . Therefore, it is thought that the level of Axin must be tightly regulated. The dephosphorylation of Axin upon Wnt signaling leads to reduced levels of Axin, indicating that phosphorylation by GSK3b is important for stability Willert et al., 1999; Yamamoto et al., 1999) . In addition, it was recently proposed that SUMOlyation of the C-terminus of Axin or PARsylation of the N-terminus, respectively, is necessary for homeostasis of Axin (Kim et al., 2008; Huang et al., 2009) .
In this work, we show that arginine methylation is a novel way to regulate the level of Axin. Recent studies have suggested that arginine methylation of proteins has critical roles in the regulation of diverse biological processes (Bedford, 2007) . Protein arginine methyltransferases (PRMTs) are responsible for this modification and are classified into two groups based on their generation of either asymmetric or symmetric dimethylarginine (Bedford and Clarke, 2009 ). Protein arginine methyltransferase 1 (PRMT1) is a type-I methyltransferase that transfers a methyl group from S-adenosylmethionine to the guanido nitrogens of arginine residues, forming monomethylarginine and asymmetric dimethylarginine (Bedford and Richard, 2005) . More than 85% of arginine methylation activity is catalyzed by PRMT1 (Tang et al., 2000) . PRMT1 has an essential, non-redundant role in embryonic development, as PRMT1À/À embryos die shortly after implantation (Pawlak et al., 2000) . A conditional PRMT1 knockout in mouse embryonic fibroblasts showed that PRMT1 is required for cell proliferation and DNA damage response signaling (Yu et al., 2009) . Moreover, arginine methylation by PRMT1 has been implicated in a variety of processes such as signal transduction, protein trafficking, transcriptional regulation, DNA repair and protein-protein interactions (McBride and Silver, 2001) .
Here, we report that PRMT1 is a novel interacting protein for Axin. Axin was directly methylated by PRMT1 both in vitro and in vivo at the 378th arginine, which is near the interaction domain for GSK3b. Knockdown or conditional knock out of PRMT1 reduced the level of Axin, whereas ectopic expression of PRMT1 led to increased Axin protein levels by blocking ubiquitination. Reduction of ubiquitination was mediated by methylation of the 378th arginine of Axin, which enhanced the association between Axin and GSK3b. Consistently, knockdown of PRMT1 increased the level of cytoplasmic b-catenin and Wnt/b-catenin signaling activity. Overall, our data suggest that PRMT1 regulated the level of Axin by methylation of the 378th arginine.
Results
Axin interacts with PRMT1 in vitro and in vivo We performed yeast twohybrid screening using Axin as bait to isolate novel interacting proteins. PRMT1 was selected as a candidate. To determine whether Axin and PRMT1 interact in vivo, immunoprecipitation experiments were performed. Immunoprecipitation with anti-Axin antibody followed by immunoblotting with anti-PRMT1, b-catenin and GSK3b antibodies using HEK-293T cell lysates suggests that PRMT1 associated with Axin complex in vivo (Figure 1a ). Co-immunoprecipitation with anti-Myc or anti-Flag antibody following transient transfection of Myc epitope-tagged 35 S]-methionine, was incubated with glutathione-sepharose bead-bound GST-PRMT1 fusion protein isoforms v1 and v2. GST-PRMT1 was pulled down by beads, after which the interaction with Axin was visualized by autoradiography. GST and GST-PRMT1 are shown by Coomassie brilliant blue (CBB) staining. (d) Colocalization of Axin and PRMT1 in vivo. Confocal fluorescence microscopy analysis using polyclonal rabbit anti-Axin antibody and monoclonal mouse anti-PRMT1 antibody show that endogenous Axin and PRMT1 are colocalized in HEK-293 cells.
Axin (Myc-Axin) and Flag epitope-tagged PRMT1 (Flag-PRMT1) into HEK-293T cells also showed a positive interaction between Axin and PRMT1 ( Figure 1b ). To investigate whether or not PRMT1 directly binds to Axin, in vitro binding assay was performed. Autoradiography observed upon incubation of bacterially purified GST-PRMT1 with in vitrotranslated Myc-Axin labeled with 35 S-methionine suggests that Axin directly interacted with PRMT1 ( Figure 1c ). We performed experiments to determine which domains interact with each other. As shown in Supplementary Figure 1A , in vitro translated Axin interacted with GST-PRMT1 or GST-PRMT1-N and did not interact with GST-PRMT1-M or GST-PRMT1-C, which suggests that the N-terminal domain of PRMT1 was necessary for interaction with Axin (Supplementary Figure 1A) . We also determined which domains of Axin are responsible for interaction with PRMT1. Interactions between GST-PRMT1-N and various in vitro translated deletion constructs were examined. Unexpectedly, all constructs interacted with GST-PRMT1 (Supplementary Figures 1B and 1C) . To further confirm these data, we performed co-immunoprecipitation experiments in HEK293T cells. Again, we observed that all deletion constructs of Axin interacted with PRMT1, which suggests that two interaction domains within fragments A and E of Axin are involved in the interaction with PRMT1 (Supplementary Figures  1C and 1D ). In addition, indirect immunofluorescence analysis shows that some of Axin and PRMT1 were mainly co-localized in the cytoplasm (Figure 1d ). Overall, our data strongly suggest that PRMT1 is a novel Axin-interacting protein.
PRMT1 methylates conserved 378th arginine residue of Axin in vitro PRMT1 is a predominant arginine methyltransferase that modulates the function of its substrates via methylation of arginine side chains at nitrogen atoms (Boisvert et al., 2005) . On the basis of our finding that PRMT1 directly interacted with Axin in vitro and in vivo, we reasoned that Axin could be a novel substrate of PRMT1. As it is technically difficult to purify fulllength Axin, GST-fused N-terminus (amino acids 1-406) and C-terminus of Axin (amino acids 407-832) were used in in vitro methylation assays. As shown in Figure 2a , only wild-type (WT) GST-PRMT1 methylated the N-terminus of Axin, compared with dominantnegative GST-PRMT1 which has no enzymatic activity (McBride et al., 2000) . PRMT1 is a type I arginine methyltransferase, a group that includes PRMT3, PRMT4/Carm1 and PRMT6 (Bedford and Clarke, 2009) , and has several splicing variants (Goulet et al., 2007) . Among them, PRMT1, PRMT3 and PRMT6 methylate substrates have a conserved glycine/argininerich (GAR) motif, whereas PRMT4/Carm1 has different motif (Boisvert et al., 2005) . To examine whether Axin is specifically methylated by PRMT1, the N-terminus of GST-Axin was incubated with PRMT1 variants (v1 and v2), PRMT3, PRMT4/Carm1 or PRMT6. Although strong methylation on GST-GAR suggests that the purified GST-PRMTs were evenly functional (Supplementary Figure 2A) , only PRMT1 and PRMT4/ Carm1 had methyltransferase activity on Axin (Figure 2b and Supplementary Figure 2B) . To identify the specific methylation site(s) in Axin, LC-MS/MS analysis was performed using the pre-methylated N-terminus of GST-Axin with GST-PRMT1 (data not shown). Then, the arginine residues of the newly identified putative methylation sites were substituted with alanine (R89A, R163A, R358A, R378A) and in vitro methylation assays were performed. Only GST-Axin-N (R378A) was resistant to methylation by PRMT1, implying that PRMT1 methylated the 378th arginine residue of Axin (Figure 2c ). Consistent with this result, fragments containing the 378th arginine residue were specifically methylated by PRMT1 in vitro (Figure 2d ). Although the 378th arginine residue of Axin is not surrounded by a conserved GAR motif (Boisvert et al., 2005) , the region was highly conserved in Axin and Axin2 among different species (Supplementary Figure 2C) . Interestingly, all mutants were methylated by PRMT4/Carm1, which does not methylate GST-GAR ( Supplementary Figures 2A and B) . Overall, these data suggest that PRMT1 methylated the 378th arginine residue of Axin in vitro whereas PRMT4/Carm1 may actually methylate other site(s).
PRMT1 methylates Axin in vivo
To test whether or not endogenous Axin is methylated by PRMT1 in vivo, Axin was immunoprecipitated from lysates of control HEK293T or shPRMT1-treated cells using anti-Axin antibody. The immunoprecipitates were subjected to immunoblotting with anti-methyl-arginine (Me-R) antibody, which specifically recognizes methylated arginine residues (Gupta et al., 2008) . As shown in Figure 3a , anti-methyl-arginine antibody detected more methylated Axin from HEK293T than shPRMT1-treated cell lysates. This result implies that Axin was methylated by endogenous PRMT1. We consistently observed that the signal intensity of Axin methylation was reduced by pre-treatment with adenosine dialdehyde (Adox), which is an inhibitor of methylation (Figure 3b) , and increased by pre-treatment with AdoMet, a methyl donor, or by ectopic expression of PRMT1 (Figure 3b-d) . To show that anti-methylarginine antibody specifically detects methylated Axin, we tested the binding of b-catenin, which is a part of the Axin complex, to anti-methyl-arginine antibody. However, as shown in Figure 3d , only Axin was specifically detected. In addition, treatment with AdoMet, a methyl donor, increased the amount of Axin detected by antimethyl-arginine antibody. To test whether or not Axin is methylated at the 378th arginine in vivo, the degree of methylation of wild-type HA-Axin and HA-Axin (R378A) were examined. As shown in Figure 3e , the methylation signal for HA-Axin (R378A) was reduced. It was possible that the reduced methylation was because of the weaker interaction of HA-Axin (R378A) with PRMT1 compared with HA-Axin. To exclude this possibility, an in vitro binding assay was performed. In vitro translated PRMT1 interacted equally well with both GST-Axin-N and GST-Axin-N (R378A), which indicates that the reduced methylation of Axin (R378A) was not because of weaker interaction with PRMT1 (Supplementary Figure 3) . Taken together, our data suggest that PRMT1 methylated Axin at the 378th arginine both in vitro and in vivo.
Methylation of Axin by PRMT1 increases the stability of Axin Treatment of cells with AdoMet increased the expression levels of inducibly expressed Axin or endogenous Axin in a time-and dose-dependent manner (Supplementary Figures 4A and B) . However, no change in the mRNA level suggests that Axin was regulated at the post-transcriptional level by methylation (Supplementary Figure 4C ). The level of Axin was increased upon co-transfection of Axin and PRMT1 into HEK293T cells, and then enhanced further by AdoMet treatment (Figure 4a ). In comparison, dominant-negative PRMT1 did not show increased level of Axin (Supplementary Figure 4D) . These data suggest that PRMT1 is sufficient for the stabilization of Axin and that methylation of Axin is important. Consistent with these data, transient knockdown of PRMT1 in HEK293T cells using short hairpin (sh)RNA resulted in reduction of endogenous Axin in an shRNA dose-dependent manner (Supplementary Figure 4E ). Measuring the level of Axin in cell lines stably expressing PRMT1 shRNA revealed an obvious correlation between the level of Axin and PRMT1 (Figure 4b and Supplementary Figure 4F) . To further confirm the role of PRMT1 in the stabilization of Axin, we have used the embryonic fibroblast cell line PRMT1 FL/-;CreERT MEF established from a conditional knockout mouse, in which PRMT1 was deleted by the addition of 4-hydroxytamoxifen (Yu et al., 2009) . The level of endogenous Axin or ectopically expressed Myc-Axin was clearly reduced in 4-hydroxytamoxifentreated cells whereas the level of co-transfected green fluorescent protein (GFP) was not changed (Figure 4c ). In addition, the level of Axin was reversed to basal level by reintroduction of wild-type Flag-PRMT1, but not by a mutant PRMT1 deficient in methylation activity (Figure 4d and Supplementary Figure 4G) . As Axin is degraded by the ubiquitin/proteasome pathway (Willert et al., 1999; Kim et al., 2008; Huang et al., 2009 ), we tested whether or not methylation of Axin by PRMT1 affects ubiquitination of Axin. Ectopic expression of PRMT1 but not dominant-negative PRMT1 inhibited the ubiquitination of Axin, whereas knockdown of PRMT1 enhanced ubiquitination (Figures 4e  and f) . Overall, our data suggest that methylation of Axin by PRMT1 stabilized Axin via the inhibition of ubiquitination.
Methylation of 378th Arg of Axin by PRMT1 enhances interaction between Axin and GSK3b
We noticed that the sequences surrounding the 378th Arg of Axin were highly conserved in Axin and Axin2 among different species (Supplementary Figure 2C) and that they were located near the GSK3b interaction domain (GID) of Axin. Thus, we inferred that the methylation of Axin by PRMT1 might have an effect on the interaction between Axin and GSK3b. Using control HEK293T cells and a PRMT knockdown stable cell line (A-8), we tested changes in the interaction between Axin and GSK3b by co-immunoprecipitation (Figure 5a) . A weaker interaction between Axin and GSK3b in the A-8 cell line compared with control cells suggest that methylation of Axin by PRMT1 enhanced the interaction between Axin and GSK3b. Transient knockdown of PRMT1 showed the same effect on the interaction between Axin and GSK3b, but this was reversed by the ectopic expression of PRMT1, which is resistant to shRNA (Figure 5b) . Moreover, treatment of cells with Adox led to a reduction in the interaction between Axin and GSK3b ( Figure 5c ). As the 378th Arg of Axin was methylated by PRMT1 (Figure 2) , we assume that the HA-Axin mutant (R378A) interacted with GSK3b less efficiently. Consistent with this assumption, the R378A mutant was co-immunoprecipitated with GSK3b about 2.5 times less compared with wild-type HA-Axin (Figure 5d) . To obtain direct evidence that the interaction between Axin and GSK3b is enhanced by methylation of the 378th Arg, an in vitro binding assay was performed. The N-termini of GST-Axin (GST-Axin-N) and GST-Axin-N (R378A) were pre-methylated with PRMT1 and then incubated with HEK293T cell lysates. GST-pull down assay followed by immunoblotting with anti-GSK3b antibody shows that pre-methylated GSTAxin interacted with GSK3b 2.1 times more efficiently than unmethylated Axin. However, pre-methylation of GST-Axin-N (R378A) did not enhance the interaction between Axin and GSK3b (Figure 5e ). This result implies that wild-type Axin as well as the R378A mutant had the same basal binding affinity for GSK3b, whereas methylation of Axin by PRMT1 enhanced the binding affinity to GSK3b. It was reported that the stability of Axin depends on interaction with and phosphorylation by GSK3b Yamamoto et al., 1999) . If not phosphorylated by GSK3b, Axin is degraded by the ubiquitin proteasome pathway (Kim et al., 2008) . Therefore, we supposed that methylation of the 378th Arg of Axin might affect the ubiquitination status in vivo. To test this assumption, wild-type Myc-Axin or mutant Myc-Axin (R378A) was co-transfected with HA-ubiquitin into HEK293T cells, and then followed by immunoprecipitation with anti-Myc antibody and immunoblotting with anti-HA antibody. As presented in Figure 5f , Myc-Axin (R378A) was much more ubiquitinated than wild-type Axin. As it was expected that mutant Axin (R378A) might be unstable because of increased ubiquitination, we compared the turnover rates of wild-type and mutant Axin (R378A) using Xenopus egg extracts (Salic et al., 2000) . in vitro translated wild-type Axin or mutant Axin (R378A) was then incubated with Xenopus egg extracts, and the samples were collected at the indicated time points in the figure in order to measure the amount of remaining Axin. The results from all three independent experiments show that mutant Axin (R378A) was much less stable than wild-type Axin (Figure 5g ). Overall, these data indicate that methylation of the 378th Arg of Axin by PRMT1 enhanced the interaction between Axin and GSK3b and prevented ubiquitination of Axin, resulting in an increase in the level of Axin.
Knockdown of PRMT1 enhances the level of cytoplasmic b-catenin and b-catenin-dependent transcription activity
Axin acts as a key negative regulator of Wnt/b-catenin signaling via degradation of cytoplasmic b-catenin (Logan and Nusse, 2004) . As the methylation of Axin by PRMT1 enhanced the level of Axin (Figure 4 ), we examined whether or not PRMT1 inhibits Wnt/bcatenin signaling. To test this hypothesis, the level of cytoplasmic or nuclear b-catenin was examined in control HEK293T and A-8 cells. As shown in Figure 6a , decreased PRMT1 enhanced the levels of cytoplasmic and nuclear b-catenin. Consistent with the reduced interaction between Axin and GSK3b in A-8 cells, the level of phosphorylated b-catenin was also decreased (Figure 6a ). Transient expression of shPRMT1 also led to the accumulation of cytoplasmic b-catenin as well as higher Axin2-promoter-luciferase and Super-TOP-FLASH reporter activity (Figures 6b and c) . Conversely, ectopic expression of PRMT1 reduced the level of cytoplasmic b-catenin and lowered Super-TOPFLASH reporter activity in A-8 cells (Figures 6d and e) . The SNU475 cell line does not express Axin due to a mutation (Satoh et al., 2000) . Therefore, to confirm that the induction of b-catenin expression and reporter activity by PRMT1 knockdown is mediated by decreased level of Axin, we performed a knockdown of PRMT1 in SNU475 cells and measured the level of cytoplasmic b-catenin. Although the level of PRMT1 was severely reduced, the cytoplasmic level of b-catenin was not increased, indicating that the induction of b-catenin by PRMT1 knockdown was mediated via downregulation of Axin (Figure 6f) . Overall, our data suggest that PRMT1 controlled the level of cytoplasmic b-catenin and Wnt/b-catenin reporter activity by regulating the level of Axin.
Discussion
Wnt/b-catenin signaling regulates diverse developmental processes and cellular proliferation by controlling the level of cytoplasmic b-catenin, leading to changes in the expression of approximately a hundred target genes (Willert and Jones, 2006) . As the level of b-catenin in the Axin complex is regulated, tight control of Axin expression is considered the key step in the transduction of Wnt/b-catenin signaling (Tolwinski and Wieschaus, 2004; Bedford, 2007) . It has been reported that several post-translational modifications, such as phosphorylation/dephosphorylation by GSK3b/protein phosphatase1 Luo et al., 2007) , SUMOlyation by SUMO-1 (small ubiquitin-related modifier) conjugating enzymes 3 (Rui et al., 2002; Kim et al., 2008) , PARsylation by tankyrases (Huang et al., 2009) and ubiquitination, are involved in controlling the stability of Axin. Although it is not yet known how these modifications are related and why so many are required, cells seem to have various checkpoints that regulate the Axin concentration as Axin is a rate-limiting factor of Wnt/b-catenin signaling and is linked to other signaling pathways such transforming growth factor b and apoptosis signaling (Luo and Lin, 2004; Salahshor and Woodgett, 2005) .
In this work, we found that methylation of arginine by PRMT1 is a novel post-translational modification mechanism for the control of Axin stability. Our data clearly show that PRMT1 directly associated with and methylated Axin both in vitro and in vivo. It has been proposed that PRMT1 has a preferred substrate motif, called the GAR motif, in which arginine residues are surrounded by one or more glycine residues (Boisvert et al., 2005) . However, the methylation site for PRMT1 in Axin does not contain this GAR motif (Supplementary Figure 2) . Nonetheless, the following data suggest that endogenous Axin was methylated by PRMT1, which then enhanced the level of Axin in vivo. First, Axin immunoprecipitated with Axin-specific antibody was detected using a methylated arginine-specific antibody, but the signal was reduced upon the addition of shPRMT1 (Figure 3) . Second, knockdown of PRMT1 reduced the level of endogenous Axin whereas increasing the level of cytoplasmic b-catenin (Figures 4 and 6 ). In addition, several published reports show that the substrates of PRMT1, such as RGC-1, Stat-1 and Runx1, can contain a non-GAR motif (Mowen et al., 2001; Teyssier et al., 2005; Zhao et al., 2008) .
We have tried to obtain a direct evidence for the methylation of 378th arginine residue by LC-MS/MS analysis. in vitro methylated GST-fused N-terminus (amino acids 1-406) was separated by SDS-polyacrylamide gel (PAGE), and the Axin band was cut out from the gel. We digested Axin with various enzymes and searched for the methylated fragment of Axin by LC-MS/MS analysis. However, our main problem was that we could not detect even the unmethylated fragment, which contains potential methylation sites. For example, when trypsin was used, we expected to see R.VPLPHIPR(378)TYR.M (if Axin is methylated) or R.VPLPHIPR.T fragment (if Axin is not methylated). However, we could not detect either fragment. Axin is known as an extremely fragile protein (Kim and Jho, 2010) . Therefore, the expected fragments may be undetectable because of the extreme instability of Axin, and Axin might be digested randomly by contaminated enzymes that are associated with trypsin or other digestive enzymes used in LC-MS/MS. In summary, we think that our evidence for the methylation of 378th arginine residue is rather indirect. However, our data clearly demonstrate that R378 was a methylation site in vivo, and its methylation regulates the stability of Axin in vivo.
PRMT1 is a predominant protein arginine methyltransferase that regulates protein-protein interactions by blocking hydrogen bond formation on nitrogen atoms and promoting hydrophobic interactions instead (Nicholson et al., 2009 ). Crystal structure analysis shows that a 25 amino acid (380-404) sequence in Axin, called GID, is the minimum domain for binding to GSK3b (Dajani et al., 2003) . Methylation of the 378th arginine residue may have induced a conformational change in Axin, which augmented its interaction with GSK3b. Bacterially purified GST-Axin-N and GST-Axin-N (R378A) interacted with GSK3b in equal amounts in vitro. However, only GST-Axin-N and not GSTAxin-N (R378A) pre-methylated by PRMT1 demonstrated enhanced interaction with GSK3b ( Figure 5e ). These results suggest that Axin interacted with GSK3b via its GID domain and that methylation near the GID domain may have enhanced the affinity between Axin and GSK3b. Interestingly, full-length wild-type Axin interacted with GSK3b more strongly in vivo than did Axin (R378A) (Figure 5d ). These data suggest that Axin was methylated in the basal state in vivo and that the methylation status of Axin may be controlled by the activity of an unidentified arginine demethylase(s).
Several reports have shown that the phosphorylation of Axin by GSK3b enhances protein stability by preventing degradation by poly-ubiquitination (Fagotto et al., 1999; Willert et al., 1999; Yamamoto et al., 1999; Kim et al., 2008) . Consistent with these reports, mutant Axin (R378A) that interacts weakly with GSK3b was more highly ubiquitinated and unstable than wild type (Figure 5f and g), and knockdown of PRMT1 clearly reduced the endogenous level of Axin ( Figure 4d ). As Axin is a tumor suppressor gene that has multiple mutations in various type of cancer (Satoh et al., 2000; Salahshor and Woodgett, 2005) , it would be very interesting to examine whether or not human cancer samples are mutated at the 378th arginine residue.
Overall, we demonstrated for the first time that methylation of arginine regulates the stability of Axin, a key component in Wnt/b-catenin signaling. Further studies to test the regulation of PRMT activity by Wnt signaling or the role of protein arginine methylation in Wnt signaling will provide new ways of controlling diseases caused by the misregulation of Wnt signaling.
Materials and methods

Plasmids
Two isoforms of mouse PRMT1 (variant 1 and 2) and PRMT4 were obtained from the total RNA of mouse embryos by RT-PCR using Pfu DNA polymerase (Stratagene, Santa Clara, CA, USA). Complementary DNAs of the two PRMT1 variants and PRMT4 were cloned into the pCMV4-Flag and pGEX-GST backbone vectors. pGEX-PRMT3, pGEX-PRMT6 and pGEX-GAR were kindly provided by Dr Herschman (UCLA, Los Angeles, CA, USA) and Dr Bedford (The University of Texas, Smithville, TX, USA). pCS2-Myc-tagged Axin, HA-tagged Axin and pGEX-GST-tagged Axin constructs were generated in the same way as described previously (Fagotto et al., 1999) . These three Axin constructs were used for site-directed mutagenesis to obtain Axin R89A, R163A, R358A and R368A. Deletion constructs of GST-Axin Nterminus (1-406), C-terminus (407-832), and were generated from pGEX-GST-Axin. pSuper-TOPFLASH reporter vector was obtained from Dr Moon (University of Washington, Seattle, WA, USA). shRNA oligonucleotide targeting PRMT1 (5 0 -ACC GCAACTCCATGTTTCA-3 0 ) was cloned into the pSuperretro-puro backbone vector (OligoEngine, Seattle, WA, USA).
Cell culture, transfection and stable cell line HEK293T human embryonic kidney cells, L929 mouse fibroblasts and SNU475 hepatoma cells were grown in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Cambrex Bio Science Walkersville, Inc., Walkersville, MD, USA) and 1 Â antibiotic-antimycotic (Invitrogen). Transient transfection of plasmids into HEK293T or L929 cells was performed by the calcium phosphate precipitation method or by using WelFect-EXTM Plus transfection reagent (WelGENE, Daegu, Korea), respectively. To generate stable cell lines expressing shRNA, HEK293T and L929 cells were transfected with pSuper-retro-puro-GFP or pSuper-retropuro-PRMT1 and then selected with 3.0 mg/ml of puromycin (Sigma, St Louis, MO, USA). To obtain SNU475 cells stably expressing shGFP or shPRMT1, retroviruses that were produced in GP2-293 cell lines were used (Clontech, Palo Alto, CA, USA). At 2 or 3 days post-transfection, the medium was collected and filtered. Before infection of retroviruses into SNU475 cells, 4.0 mg/ml of polybrene (Sigma) was added to the medium. The pool of puromycin-resistant cells was selected in medium containing 2.0 mg/ml of puromycin for 1 week. The PRMT1 conditional knockout mouse embryonic fibroblast cell line (PRMT1 FL/-;CreERT MEF) was kindly provided by Dr Richard (McGill University, Montreal, Quebec, Canada).
Immunoprecipitation, immunoblotting and antibodies Cells were lysed in lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1.0% Triton X-100, 20 mM NaF, 2 mM EDTA, 2 mM Na-orthovanadate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 5 mg/ml leupeptin A), after which the concentration of proteins was measured using Bradford reagent (Bio-Rad, Hercules, CA, USA). For immunoprecipitation, 600-800 mg of cell lysates was incubated with proper antibody in lysis buffer overnight at 4 1C with constant rotation. To detect methylation of endogenous Axin, 2000 mg of cell lysates was used for the immunoprecipitation of Axin. The immunoprecipitates were analyzed by SDS-PAGE and immunoblotting. Rabbit polyclonal anti-Axin antibody was kindly provided by Dr Virshup (University of Utah, Salt Lake City, UT, USA) and purchased from R&D systems (Minneapolis, MN, USA). In vitro methylation assay in vitro methylation assays were performed as described previously (Bedford et al., 2000) . In brief, GST-PRMT1 (mouse), PRMT3 (mouse), PRMT4 (mouse), PRMT6 (Rat) and various GST-Axin constructs were purified using Glutathione-Agarose 4B (Peptron, Daejeon, Korea). Various GST-Axin constructs (1-2 mg) and GST-GAR (0.5 mg) were incubated with the indicated GST-PRMTs (0.2-2.0 mg) in the presence of 2 ml of S-adenosyl-L-[methyl-
3 H] methionine ([ 3 H]-AdoMet; 83.3 ci/mmol, Perkin-Elmer) for 90 min at 37 1C in 50 ml of methylation reaction buffer (15 mM Tris-HCl (pH 7.5), 25 mM NaCl, 10 mM EDTA). The methylation reactions were stopped by the addition of 4 Â SDS sample buffer, followed by heating 100 1C for 10 min. The samples were loaded onto 10% SDS-PAGE and stained with 0.05% Coomassie Brilliant Blue. After destaining, gels were soaked in EN 3 HANCE (Perkin-Elmer, Waltham, MA, USA) according to the manufacturer's instructions and visualized by fluorography after exposure for 2 weeks at À80 1C.
Preparation of cytoplasmic and nuclear fractions
The subcellular fractionation protocol has been described previously (Lyu et al., 2008) . To separate cytoplasmic and nuclear proteins, cells were washed twice in phosphatebuffered saline (PBS) and collected in hypertonic buffer (50 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM Na 3 VO 4 , 50 mM NaF, 1 mM PMSF, 5 mg/ml of leupeptin A). After being incubated on ice for 30 min, cells were lysed by being passed 25 times through a 26-gauge needle. The lysates were centrifuged at 800 g for 5 min at 4 1C. The pellets were collected as the nuclear fraction, after which the low-speed supernatant was subsequently ultracentrifuged at 100 000 g for 30 min at 4 1C. The resulting supernatant was collected as the cytoplasmic fraction. The nuclear fraction was washed two times with cold PBS and incubated in hypotonic buffer containing 1% Triton X-100 and 150 mM NaCl for 30 min on ice with occasional pipetting. The nuclear fraction sample was isolated by centrifugation at 16 000 g for 25 min at 4 1C.
Luciferase assay
To measure the activity of Wnt/b-catenin signaling, luciferase assays were performed as described previously (Jung et al., 2009) . The luciferase activities were measured by DualLuciferase luminometer (Promega, Madison, WI, USA) in accordance with standard procedures.
Immunofluorescence analysis HEK293T cells were seeded onto glass coverslips in six-well plates, fixed for 20 min in 4% paraformaldehyde in PBS, and then permeabilized for 20 min with 0.4% Triton X-100 in PBS at room temperature. Samples were washed three times with PBS, preblocked with 5% bovine serum albumin (Sigma) in PBST (0.05% Tween 20 in PBS) for 30 min, and then incubated with rabbit polyclonal anti-Axin antibody and mouse monoclonal anti-PRMT1 antibody for 1 h at room temperature. Samples were then rinsed three times with PBST and incubated with the secondary antibodies Alexa-Fluor antibodies 488 and 633 (Invitrogen) for 1 h. Localization of proteins was analyzed using confocal microscopy (LSM510 (Zeiss)).
Preparation of Xenopus egg extract and axin degradation assay Egg extracts were prepared as described previously (Jernigan et al., 2010) . Briefly, de-jellied unfertilized Xenopus eggs were crushed by centrifugation (16 000 r.p.m. for 2 min at 4 1C), and cytosolic extracts were collected. The final extract (B50 mg/ml) was used in the experiments. Axin degradation assay was performed similarly as previously published (Salic et al., 2000) . in vitro translated [
S]-Myc-Axin or [
35 S]-Myc-Axin (R378A) was incubated with 10 ml of egg extracts, 0.5 ml of cycloheximide (100 mg/ml), 0.5 ml of energy regeneration buffer (Enzo Life Sciences, Inc., Plymouth Meeting, PA, USA) and 0.5 ml of human ubiquitin (10 mg/ml, BostonBiochem, Cambridge, MA, USA) at 30 1C. The samples were collected at the indicated time points in the figure, and the amount of remaining Axin was visualized by autoradiography after separation by SDS-PAGE.
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